Publication | Closed Access

Icotinib versus chemotherapy as adjuvant treatment for stage II–IIIA EGFR-mutant non-small-cell lung cancer (EVIDENCE): a randomised, open-label, phase 3 trial

MedicineImmunologyPathologyAdjuvant TreatmentImmune Checkpoint InhibitorCancer TreatmentOncologyRadiation OncologyLung CancerMolecular OncologyIcotinib Versus Chemotherapy